儿童肾活检优化:针头尺寸与穿刺次数的影响
本研究纳入2019年3月至2022年2月单中心145例儿童原生肾活检,比较16G与18G针及穿刺次数对并发症和肾小球获取量的影响。结果显示18G与16G并发症率无显著差异,但并发症随穿刺次数增加;16G肾小球获取量更高,18G与取样不足相关;16G针1–2次穿刺为最佳方案。
要点
- 16G针较18G针肾小球获取量更高(34.6 vs 22.6,p<0.001)。
- 并发症率随穿刺次数增加(p<0.001),3次及以上穿刺应避免。
- 18G针与取样不足相关(p=0.024),16G针1–2次穿刺为最佳方案。
核心结论
- 实时超声引导下儿童肾活检是安全的。
- 16G针1–2次穿刺可优化肾小球获取量而不增加并发症。
- 应避免3次及以上穿刺。
研究设计与样本
- 单中心回顾性研究,纳入2019年3月至2022年2月在一家三级儿童医院进行的儿童原生肾活检。
- 共145例患儿,女59.3%、男40.7%,平均年龄10.74(±4.69)岁。
- 2020年12月前使用半自动16G针,之后使用18G针,穿刺次数不定。
- 活检后24小时行超声检查评估并发症。
- 按针头尺寸和穿刺次数分为六个亚组,比较并发症率、肾小球获取量和诊断充分性。
诊断标准与关键数值
- 18G针用于76例(52.4%),16G针用于69例(47.6%)。
- 轻微并发症56例(38.6%),无严重并发症。
- 18G与16G并发症率无显著差异(p=0.088),但并发症率随穿刺次数增加(p<0.001)。
- 16G平均肾小球获取量高于18G(34.6 vs 22.6,p<0.001),穿刺次数对肾小球获取量无显著影响(p=0.123)。
- 18G针与取样不足相关(p=0.024)。
临床应用与阅片要点
- 实时超声引导下儿童肾活检中,采用16G针行1–2次穿刺可在不增加并发症的情况下优化肾小球获取量。
- 应避免3次及以上穿刺。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study evaluated the impact of needle size and the number of passes on complication rates and glomerular yield in pediatric native kidney biopsies performed under real-time ultrasound (US) guidance, aiming to determine the optimal biopsy approach.
MATERIALS AND METHODS: Pediatric native kidney biopsies performed between March 2019 and February 2022 at a single tertiary-care children's hospital were included. Biopsies were done with a semi-automated 16 G needle until December 2020, then with an 18 G needle, with varying numbers of passes. US examinations were conducted 24 h post-biopsy to assess complications. Patients were categorized into six subgroups using needle size and the number of passes and compared for complication rates, glomerular yield, and diagnostic adequacy.
RESULTS: A total of 145 pediatric patients (59.3% female, 40.7% male) with a mean age of 10.74 (±4.69) years were included. An 18 G needle was used in 76 (52.4%) cases and a 16 G needle in 69 (47.6%) cases. Minor complications occurred in 56 (38.6%) cases, with no major complications. Complication rates were not significantly different between 18 G and 16 G (p=0.088) but increased with the number of passes (p<0.001). Mean glomerular yield was higher with 16 G than 18 G (34.6 vs. 22.6, p<0.001), though not significantly affected by the number passes (p=0.123). The 18 G needle was associated with inadequate sampling (p=0.024). The optimal scenario was a 16 G needle with one or two passes.
CONCLUSION: Real-time US-guided pediatric kidney biopsy is safe. A 16 G needle with one or two passes optimizes glomerular yield without increasing complications. Three or more passes should be avoided.
引用
- Yasar Y, Coskun M, Yasar E, et al. Optimization of Pediatric Kidney Biopsy: Impact of Needle Size and Passes. Acad Radiol. 2025. PMID: 40274519. doi:10.1016/j.acra.2025.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。